The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults
The Lancet Healthy Longevity2021Vol. 2(6), pp. e340–e351
Citations Over TimeTop 1% of 2021 papers
David Flood, Jacqueline A. Seiglie, Matthew R. Dunn, Scott Tschida, Michaela Theilmann, Maja E. Marcus, Garry Brian, Болормаа Норов, Mary Mayige, Mongal Singh Gurung, Krishna Kumar Aryal, Demetre Labadarios, Maria Dorobanţu, Silver Bahendeka, Pascal Bovet, Jutta M Adelin Jorgensen, David Guwatudde, Corine Houéhanou, Glennis Andall‐Brereton, Sarah Quesnel-Crooks, Lela Sturua, Farshad Farzadfar, Sahar Saeedi Moghaddam, Rifat Atun, Sebastián Vollmer, Till Bärnighausen, Justine Davies, Deborah J. Wexler, Pascal Geldsetzer, Peter Rohloff, Manuel Ramírez‐Zea, Michele Heisler, Jennifer Manne‐Goehler
Abstract
Fewer than one in ten people with diabetes in LMICs receive coverage of guideline-based comprehensive diabetes treatment. Scaling-up the capacity of health systems to deliver treatment not only to lower glucose but also to address cardiovascular disease risk factors such as hypertension and high cholesterol are urgent global diabetes priorities.
Related Papers
- → Challenges of COVID-19 testing in low-middle income countries (LMICs): the case of Malawi(2020)18 cited
- → Local coalitions as an underutilized and understudied approach for promoting tobacco control in low- and middle-income countries(2018)4 cited
- → The effectiveness of policies promoting facility-based deliveries in reducing maternal and infant morbidity and mortality in low and middle-income countries(2018)1 cited
- → FREQUENCY OF DIABETES MELLITUS IN PATIENTS WITH COVID-19 INFECTION(2023)
- → Review for "Delivery platforms for reaching adolescents with nutrition interventions in low‐ and middle‐income countries"(2024)